Solana’s Surge: A Pharmaceutical Firm’s Cryptic Leap into Crypto đđ°
And what event, you might ask, could possibly be more significant than the whims of the market? Why, the decision of Artelo Biosciences, a clinical-stage pharmaceutical firm, to adopt Solana as part of its corporate treasury. Yes, you read that correctly. In a move that would have made the great Dostoevsky himself scratch his head in wonder, Artelo became the first publicly traded pharmaceutical company to embrace the digital realm of SOL. With a commitment of $9.475 million from an at-the-market private placement, Artelo has set sail into uncharted waters, guided by the beacon of Solanaâs promise.